EUVIMEDEUVIMED entdecken
Open Access

Exploring Willingness to Use Long-Acting Injectable PrEP Among Sexual and Gender Minoritized People Accessing Pharmacies

Daniel I Alohan, Christina Chandra, Henry N Young, Alvan Quamina, David P Holland, Natalie D Crawford

AIDS Education and Prevention · 2025

DOI: 10.1521/aeap.2025.37.2.107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIDS Education and Prevention, 2025. Verfasst von Daniel I Alohan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, Georgia. Hauptthemen laut MEDLINE: HIV Infections, Pre-Exposure Prophylaxis, Patient Acceptance of Health Care, Anti-HIV Agents. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This mixed-methods study explored willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among a pharmacy-based sample of men, including sexual and gender minoritized (SGM) individuals. We conducted qualitative interviews (n = 10) with HIV-negative Black men, including Black SGM individuals, and surveys (n = 103) across three study phases with men recruited from community pharmacies in Atlanta, Georgia. Interviews explored perceived benefits and concerns related to LAI-PrEP; surveys assessed willingness and related reasons. Thematic analysis was used for interview transcripts, and descriptive statistics summarized survey responses. Participants mentioned benefits such as improved adherence and reduced stigma, but also noted concerns about medical mistrust and fear of needles. Willingness was higher in the transitional pilot phase than in the pilot phase, where concerns about side effects and comfort were more common. Findings highlight the need for tailored LAI-PrEP strategies that address barriers among Black SGM populations and promote equitable HIV prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsPre-Exposure ProphylaxisPatient Acceptance of Health CareAnti-HIV AgentsSexual and Gender MinoritiesHumansMaleAdultGeorgiaInterviews as TopicQualitative ResearchMiddle AgedBlack or African AmericanPharmaciesYoung AdultInjectionsSurveys and QuestionnairesAdolescentSocial StigmaHealth Knowledge, Attitudes, Practice

Stichwörter der Autor:innen

HIVPrEPlong-acting injectablesexual minority mentransgender individuals

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, Georgia.
  • Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.
  • Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Georgia, Athens, Georgia.
  • NAESM, Inc., Atlanta, Georgia.
  • Mercy Care, Atlanta, Georgia.

Förderung

  • NIMH NIH HHS
  • NIDA NIH HHS

Zitieren

APA

Alohan, D. I., Chandra, C., Young, H. N., Quamina, A., Holland, D. P., & Crawford, N. D. (2025). Exploring Willingness to Use Long-Acting Injectable PrEP Among Sexual and Gender Minoritized People Accessing Pharmacies. AIDS Education and Prevention. https://doi.org/10.1521/aeap.2025.37.2.107

Vancouver

Alohan DI, Chandra C, Young HN, Quamina A, Holland DP, Crawford ND. Exploring Willingness to Use Long-Acting Injectable PrEP Among Sexual and Gender Minoritized People Accessing Pharmacies. AIDS Education and Prevention. 2025. doi:10.1521/aeap.2025.37.2.107

BibTeX
@article{Alohan2025,
  author = {Alohan, Daniel I and Chandra, Christina and Young, Henry N and Quamina, Alvan and Holland, David P and Crawford, Natalie D},
  title = {Exploring Willingness to Use Long-Acting Injectable PrEP Among Sexual and Gender Minoritized People Accessing Pharmacies},
  journal = {AIDS Education and Prevention},
  year = {2025},
  doi = {10.1521/aeap.2025.37.2.107}
}
Kostenlos starten →